Related Experiment Video
Updated: Sep 14, 2025
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Low-Density Lipoprotein Cholesterol as a Protective Factor in COPD and Implications for Statin Therapy: A Multi-Omics
Tiantao Du1, Jianye Cao1, Ziyao Dai1
1Clinical Medical College, Southwest Medical University, Luzhou, People's Republic of China.
Background:
Chronic obstructive pulmonary disease (COPD) is a complex lung condition primarily affecting the airways and alveoli, characterized by persistent progressive airflow limitation. COPD ranks as the third leading cause of death worldwide, with its incidence and mortality rates escalating annually due to an aging population. This study aimed to explore the association between low-density lipoprotein cholesterol (LDL-C) and COPD, as well as the impact of statin drugs on the progression of COPD.
Methods:
Employing an integrated approach that encompasses observational studies, genetic epidemiology, and molecular biology, this research investigated the link between LDL-C and COPD using clinical survey data, genome-wide association study (GWAS) data, and transcriptomic data. Additionally, it assessed the potential role of statin drugs in the treatment of COPD.
Results:
The study discovered that LDL-C serves as a protective factor for COPD, and statin drugs may promote the progression of COPD by reducing LDL-C levels. This finding provides a new perspective on the metabolic disruptions in COPD and offers significant guidance for future therapeutic strategies.
Conclusion:
This research confirms the inverse correlation between LDL-C and COPD and reveals that statin drugs might influence the progression of COPD by affecting LDL-C levels. These findings underscore the importance of considering metabolic factors in COPD management and suggest new directions for therapeutic strategies.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:26Coronary Artery Disease IV: Preventive Measures
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation